NCT05315141 Multicenter Cohort Study of AAV in Hunan of China
| NCT ID | NCT05315141 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Xiangya Hospital of Central South University |
| Condition | ANCA Associated Vasculitis |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2022-03-16 |
| Primary Completion | 2027-03-16 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2022-03-16 with a primary completion date of 2027-03-16.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aimed to explore the incidence of Anti-neutrophil cytoplasmic antibody (ANCA）-associated vasculitis (AAV) progression and its association with adverse consequences. It will enroll approximately 500 AAV patients in Hunan province of China and follow-up for at least 5 years. Demographic characteristics, clinical and laboratory data will be collected at baseline and every follow-up. The principal clinical outcomes of the study consist of end stage renal disease (ESRD) and death.
Eligibility Criteria
Inclusion Criteria: * Fulfill 2012 criteria of ANCA associated vasculitis and agree to sign informed consent Exclusion Criteria: * Do not agree to sign informed consent
Contact & Investigator
Xiangcheng Xiao, doctor
PRINCIPAL INVESTIGATOR
Xiangya Hospital of Central South University
Frequently Asked Questions
Who can join the NCT05315141 clinical trial?
This trial is open to participants of all sexes, studying ANCA Associated Vasculitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05315141 currently recruiting?
Yes, NCT05315141 is actively recruiting participants. Contact the research team at zhongyong121@163.com for enrollment information.
Where is the NCT05315141 trial being conducted?
This trial is being conducted at Changsha, China.
Who is sponsoring the NCT05315141 clinical trial?
NCT05315141 is sponsored by Xiangya Hospital of Central South University. The principal investigator is Xiangcheng Xiao, doctor at Xiangya Hospital of Central South University. The trial plans to enroll 500 participants.